Ngā hua rapu - Frank Vari

  • E whakaatu ana i te 1 - 8 hua o te 8
Whakamahine hua
  1. 1
    Serum CD163 and TARC as Disease Response Biomarkers in Classical Hodgkin Lymphoma

    Serum CD163 and TARC as Disease Response Biomarkers in Classical Hodgkin Lymphoma mā Kimberley Jones, Frank Vari, Colm Keane, Pauline Crooks, Jamie P. Nourse, Louise Seymour, David Gottlieb, David Ritchie, Devinder Gill, Maher K. Gandhi

    I whakaputaina 2012
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    EBV microRNA-BHRF1-2-5p targets the 3′UTR of immune checkpoint ligands PD-L1 and PD-L2

    EBV microRNA-BHRF1-2-5p targets the 3′UTR of immune checkpoint ligands PD-L1 and PD-L2 mā Alexandre S. Cristino, Jamie P. Nourse, Rachael A. West, Muhammed B. Sabdia, Soi Cheng Law, Jay Gunawardana, Frank Vari, Sally Mujaj, Gayathri Thillaiyampalam, Cameron Snell, Madeline Gough, Colm Keane, Maher K. Gandhi

    I whakaputaina 2019
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Immune evasion via PD-1/PD-L1 on NK cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL

    Immune evasion via PD-1/PD-L1 on NK cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL mā Frank Vari, David Arpon, Colm Keane, Mark Hertzberg, Dipti Talaulikar, Sanjiv Jain, Qingyan Cui, Erica Han, Joshua W.D. Tobin, Robert Bird, Donna Cross, Annette Hernandez, Clare Gould, Simone Birch, Maher K. Gandhi

    I whakaputaina 2018
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    The impact of HLA class I and EBV latency-II antigen-specific CD8+ T cells on the pathogenesis of EBV+ Hodgkin lymphoma

    The impact of HLA class I and EBV latency-II antigen-specific CD8+ T cells on the pathogenesis of EBV+ Hodgkin lymphoma mā Kimberley Jones, Leesa Wockner, R.M. Brennan, Colm Keane, Pratip K. Chattopadhyay, Mario Roederer, David A. Price, David K. Cole, Brekhna Hassan, Konrad Beck, David Gottlieb, David Ritchie, John F. Seymour, Frank Vari, Pauline Crooks, Scott R. Burrows, Maher K. Gandhi

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    The T-cell Receptor Repertoire Influences the Tumor Microenvironment and Is Associated with Survival in Aggressive B-cell Lymphoma

    The T-cell Receptor Repertoire Influences the Tumor Microenvironment and Is Associated with Survival in Aggressive B-cell Lymphoma mā Colm Keane, Clare Gould, Kimberley Jones, David Hamm, Dipti Talaulikar, Jonathan Ellis, Frank Vari, Simone Birch, Erica Han, Peter Wood, Kim‐Anh Lê Cao, Michael R. Green, Pauline Crooks, Sanjiv Jain, Joshua W.D. Tobin, Raymond J. Steptoe, Maher K. Gandhi

    I whakaputaina 2016
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Progression of Disease Within 24 Months in Follicular Lymphoma Is Associated With Reduced Intratumoral Immune Infiltration

    Progression of Disease Within 24 Months in Follicular Lymphoma Is Associated With Reduced Intratumoral Immune Infiltration mā Joshua W.D. Tobin, Colm Keane, Jay Gunawardana, Peter Mollee, Simone Birch, Thanh Hoang, Justina Lee, Li Li, Li Huang, Valentine Murigneux, J. Lynn Fink, Nicholas Matigian, Frank Vari, Santiyagu M. Savarimuthu Francis, Robert Kridel, Oliver Weigert, Sarah Haebe, Vindi Jurinović, Wolfram Klapper, Christian Steidl, Laurie H. Sehn, Soi Cheng Law, Michelle Wykes, Maher K. Gandhi

    I whakaputaina 2019
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity

    EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity mā Maher K. Gandhi, Thanh Hoang, Soi Cheng Law, Sandra Brosda, Kacey O’Rourke, Joshua W.D. Tobin, Frank Vari, Valentine Murigneux, J. Lynn Fink, Jay Gunawardana, Clare Gould, Harald Oey, Karolina Bednarska, Susanne Delécluse, Ralf Ulrich Trappe, Lilia Merida de Long, Muhammed B. Sabdia, Govind Bhagat, Greg Hapgood, Emily Blyth, Luke Clancy, Joel Wight, Eliza A. Hawkes, Lisa M. Rimsza, Alanna Maguire, Kamil Bojarczuk, Bjoern Chapuy, Colm Keane

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8+ T Cells

    CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8+ T Cells mā Matthias Braun, Amelia Roman Aguilera, Ashmitha Sundarrajan, Dillon Corvino, Kimberley Stannard, Sophie Krumeich, Indrajit Das, Luize Goncalves Lima, Lizeth G. Meza Guzman, Kunlun Li, Rui Li, Nazhifah Salim, Maria Villancanas Jorge, Sunyoung Ham, Gabrielle Kelly, Frank Vari, Ailin Lepletier, Ashwini Raghavendra, Sally‐Ann Pearson, Jason Madore, Sébastien Jacquelin, Maike Effern, Brodie Quine, Lambros T. Koufariotis, Mika Casey, Kyohei Nakamura, Eun Young Seo, Michael Hölzel, Matthias Geyer, Glen Kristiansen, Touraj Taheri, Elizabeth Ahern, Brett Hughes, James S. Wilmott, Georgina V. Long, Richard A. Scolyer, Martin Batstone, Jennifer Landsberg, Dimo Dietrich, Oltin T. Pop, Lukas Flatz, William C. Dougall, André Veillette, Sandra E. Nicholson, Andreas Möller, Robert J. Johnston, Ludovic Martinet, Mark J. Smyth, Tobias Bald

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: